Low HMGCS2 expression is a poor prognostic factor in colorectal cancer, esophageal squamous cell carcinoma, prostate cancer, and hepatocellular carcinoma.28, 29, 32, 33. This evidence concerns the gene HMGCS2 and prostate carcinoma.